STAT+: Trump administration prepares 100% tariffs on some imported drugs
Why it matters: A 100% tariff on imported drugs could double the cost of some medicines for US consumers.
- The White House is preparing a 100% tax on some imported medicines, as indicated by a draft order.
- The NIH director is invoking Vannevar Bush's legacy to promote Trump administration science policies, a move that has generated pushback.
- The proposed tariffs on imported drugs could have substantial implications for the pharmaceutical supply chain and consumer prices.
The Trump administration is preparing to impose a 100% tariff on certain imported drugs, according to a draft order, a move that could significantly impact drug accessibility and cost. This policy comes amidst broader discussions about the administration's science policies, with the NIH director referencing Vannevar Bush's legacy to promote these initiatives, sparking debate and pushback.
